As of Oct 18
| -0.0021 / -0.43%|
The 3 analysts offering 12-month price forecasts for Oncolytics Biotech Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 6.80. The median estimate represents a +1,543.05% increase from the last price of 0.49.
The current consensus among 3 polled investment analysts is to Buy stock in Oncolytics Biotech Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.